Glossary term

FDA shortage list

A registry of medications in short supply. While on the list, 503A pharmacies can legally compound the medication. Semaglutide and tirzepatide were removed from the shortage list in 2025.

Related Procedures

FDA shortage list appears in the following procedure guides on ProcedureFinder:

Weight Loss

Semaglutide for Weight Loss

Weekly GLP-1 receptor agonist injection that reduces appetite and food cravings, typically producing 12 to 17 percent body weight loss over 12 months.

← Browse the full glossary